MediciNova (NASDAQ:MNOV) Now Covered by Analysts at StockNews.com
StockNews.com started coverage on shares of MediciNova (NASDAQ:MNOV – Free Report) in a research note published on Wednesday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Separately, D. Boral Capital started coverage on shares of MediciNova in a research report on Monday, December 2nd. They issued a “buy” rating and a $9.00 […]
StockNews.com started coverage on shares of MediciNova (NASDAQ:MNOV – Free Report) in a research note published on Wednesday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Separately, D. Boral Capital started coverage on shares of MediciNova in a research report on Monday, December 2nd. They issued a “buy” rating and a $9.00 […]
